Ionis PharmaceuticalsIONS
那斯達克 · USD
79.44
+1.91
(+2.46%)
收盤 01/22 04:59 (UTC+8)
01/22 04:59 (UTC+8)
Ionis PharmaceuticalsIONS
79.44
+1.91
(+2.46%)
財務數據
損益表
- 1.88
- 1.44
- 3.25
- 1.19
- 2.25
- 1.34
- 2.27
- 1.32
- 4.52
- 1.57
- 44.35
- -23.46
- 125.03
- -63.18
- 88.50
- -40.59
- 69.32
- -41.91
- 243.47
- -65.33
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 156,721 | 452,048 | 131,612 | 226,576 | 133,814 | 225,251 | 119,497 | 324,505 | 144,207 | 188,411 |
營業成本 | 2,338 | 4,151 | 1,463 | 3,830 | 1,071 | 4,163 | 2,151 | 3,062 | 2,191 | 2,537 |
營業毛利 | 154,383 | 447,897 | 130,149 | 222,746 | 132,743 | 221,088 | 117,346 | 321,443 | 142,016 | 185,874 |
營業費用 | 314,563 | 308,082 | - | 333,569 | 281,397 | - | 266,859 | 327,566 | 285,280 | 276,069 |
研發費用 | 217,754 | 217,460 | 200,759 | 245,490 | 219,760 | 222,065 | 214,215 | 256,555 | 215,330 | 229,927 |
推銷及管理費用 | 96,809 | 90,622 | 76,250 | 88,079 | 61,637 | 65,114 | 52,644 | 71,011 | 69,950 | 46,142 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -160,180 | 139,815 | -146,860 | -110,823 | -148,654 | -66,091 | -149,513 | -6,123 | -143,264 | -90,195 |
其他收入及費用 | 53,949 | 6,479 | 22,968 | 26,644 | 27,249 | 22,676 | 28,895 | 25,763 | 24,437 | 32,694 |
利息費用 | 22,163 | 22,763 | 22,930 | 22,860 | 22,696 | 22,785 | 22,110 | 22,407 | 21,981 | 19,946 |
稅前純益 | -128,394 | 123,531 | -146,822 | -107,039 | -144,101 | -66,200 | -142,728 | -2,767 | -140,808 | -77,447 |
所得稅 | 212 | -20 | 116 | -2,690 | -3,621 | 65 | 75 | 6,496 | 6,602 | 7,843 |
稅後純益 | -128,606 | 123,551 | -146,938 | -104,349 | -140,480 | -66,265 | -142,803 | -9,263 | -147,410 | -85,290 |
基本每股稅後盈餘(元) | -0.80 | 0.78 | -0.93 | -0.66 | -0.95 | -0.45 | -0.98 | -0.06 | -1.03 | -0.60 |
稀釋每股稅後盈餘(元) | -0.80 | 0.78 | -0.93 | -0.66 | -0.95 | -0.45 | -0.98 | -0.06 | -1.03 | -0.60 |
基本平均股數(千股) | 160000.00 | 159000.00 | 159000.00 | 158000.00 | 149000.00 | 145958.00 | 146000.00 | 144000.00 | 143000.00 | 143000.00 |
稀釋平均股數(千股) | 160000.00 | 182000.00 | 159000.00 | 158000.00 | 149000.00 | 145958.00 | 146000.00 | 144000.00 | 143000.00 | 143000.00 |
還原基本每股稅後盈餘(元) | -0.80 | 0.78 | -0.93 | -0.66 | -0.95 | -0.45 | -0.98 | -0.06 | -1.03 | -0.60 |
還原稀釋每股稅後盈餘(元) | -0.80 | 0.78 | -0.93 | -0.66 | -0.95 | -0.45 | -0.98 | -0.06 | -1.03 | -0.60 |
還原基本平均股數(千股) | 160,000 | 159,000 | 159,000 | 158,000 | 149,000 | 145,958 | 146,000 | 144,000 | 143,000 | 143,000 |
還原稀釋平均股數(千股) | 160,000 | 182,000 | 159,000 | 158,000 | 149,000 | 145,958 | 146,000 | 144,000 | 143,000 | 143,000 |
EBITDA(千元) | -105,162 | 147,524 | -123,961 | -86,688 | -123,374 | -46,051 | -122,557 | 18,427 | -119,451 | -57,771 |